Systematic review on treatments for relapsing-remitting multiple sclerosis
A systematic review on the efficacy and safety of disease-modifying drugs in relapsing-remitting multiple sclerosis, including 50 studies with 36,541 participants and 29 drugs, was recently published by our review group in the Cochrane Library. Through a network meta-analysis, both direct and indirect comparisons were considered.